SPAC Deal for Diamond Retailer Blue Nile and Online Travel Booker Holisto

by | Jun 13, 2022

Deal termination for BIOT/Blade Therapeutics. Two merger votes this week. And the rest of the day’s news in SPACs.

Free Investor Resources from Boardroom Alpha
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

BIOT / Blade Therapeutics Deal Termination

Biotech Acquisition Corp. (BIOT) terminates deal with biopharma Blade Therapeutics. BAC will continue to look for another target.

Deal Announcement: MACA / Holisto

Moringa Acquisition Corp. (MACA) announces DA with Holisto, “a technology based online travel booking platform.” Implied pro forma equity value is approximately $405M. No PIPE; $30M convertible. Expected close during the fourth quarter of 2022. Slide deck here.

Deal Announcement: MUDS / Blue Nile

Mudrick Capital Acquisition Corp. II (MUDS) announces DA with Blue Nile, an online retailer of conflict-free natural diamonds. The transaction values Blue Nile at a pro forma implied equity value of $873M and is expected to generate approximately $450 million of capital before expenses (assuming no redemptions). $321M in trust. Includes an $80M PIPE (~$50M of which has been pre-funded by MUDS). Existing Blue Nile shareholders will retain 39% of the combined company’s pro forma equity.

Two merger votes this week

Merger votes for Virgin Group Acquisition Corp. II (VGII) and sustainable consumer products company Grove Collaborative and EJF ACquisition Corp. (EJFA) and AI infrastructure player Pagaya Technologies.

SPAC Daily Movers

Source: Boardroom Alpha

SPAC Calendar

Source: Boardroom Alpha

More from Boardroom Alpha

For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

<a href="" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – December 2021

2021 is drawing to a close and what a year it was for SPACs. In our December market update we take a look at the last month of the year and give our latest thoughts on the market, including: record IPO issuance and SPAC supply; aging SPACs and outlook for terminations; and the merger market including its financing evolution

SPAC Research & Analysis

Moroccan Agribusiness Forafric debuts

Moroccan agribusiness Forafric (AFRI) debuts. With TCAC / Springbig approved at 96% redemptions, we take a look at redemption trends. Lots of extension votes coming up. And the rest of the day’s news in SPACs.

Warehouse Robot Maker Symbotic Gets Juiced

Shares of warehouse robot maker Symbotic (SYM) join the high redemption/thin float club, popping 120% on today’s debut. Merger approval for DYNS/ Senti Bio. The usual extensions. And the rest of the day’s news in SPACs.

SVFC / Symbotic Approved

SVFC approves Symbotic merger. SPACs are busy with 4 merger votes this week. Fingers crossed…lots of extension votes. And the rest of the day’s news in SPACs.

Blade Therapeutics Vote Delayed

The race against the clock continues. BIOT says it has enough votes for its merger with Blade Therapeutics, but needs more time to close. And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.